Multiple T-lymphocyte-related proteins

The term Multiple T-lymphocyte-related proteins does not refer to a single, specific therapeutic target but rather serves as a collective descriptor for a diverse group of proteins expressed on or within T-lymphocytes. This category encompasses various functional classes, including T-cell receptors (TCRs), co-stimulatory molecules (e.g., CD28), co-inhibitory checkpoint receptors (e.g., PD-1, CTLA-4), and lineage-specific markers (e.g., CD3, CD4, CD8). These proteins are fundamental to the orchestration of the adaptive immune response, governing T-cell activation, differentiation, and effector functions. In clinical and pharmacological contexts, drugs often target specific members of this group to modulate immune activity, such as using checkpoint inhibitors for oncology or immunosuppressants for autoimmune disorders. Because the term is non-specific and aggregates many distinct proteins with different biological roles, it is generally considered an incorrect or overly broad designation for a single drug target.

Other names

T-cell surface antigensT-lymphocyte markers

Not applicable as this refers to a broad category of proteins rather than a single therapeutic target.